What is the current Global Genomics in Cancer Care Market size?

The Global Genomics in Cancer Care Market is projected to register a CAGR of 12.5% during the forecast period (2024-2029) Read More

Who are the key players in Global Genomics in Cancer Care Market?

Agilent Technologies, Illumina, Inc. , Pacific Biosciences, Inc. , ThermoFisher Scientific Inc. and Intrexon Bioinformatics Germany GmbH are the major companies operating in the Global Genomics in Cancer Care Market. Read More

Which is the fastest growing region in Global Genomics in Cancer Care Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Genomics in Cancer Care Market?

In 2024, the North America accounts for the largest market share in Global Genomics in Cancer Care Market. Read More

What years does this Global Genomics in Cancer Care Market cover?

The report covers the Global Genomics in Cancer Care Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Genomics in Cancer Care Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Genomics in Cancer Care Market

Genomics in Cancer Care Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Genomics in Cancer Care Market is segmented by product type (Instruments, Consumables, and Services), by technology (PCR, MicroArrays, Genome Sequencing, and others), and by geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Genomics in Cancer Care Industry Overview

The Genomics in Cancer Care Market is moderately competitive. Some companies currently dominating the market are Illumina Inc., ThermoFisher Scientific Inc., Agilent Technologies, Cancer Genetics Inc., GE Healthcare (GE Company), Intrexon Bioinformatics Germany GmbH, Quest Diagnostics, Merck KGaA, Pacific Biosciences, Inc. among others.